KURA RSI Chart
Last 7 days
-4.2%
Last 30 days
3.8%
Last 90 days
56.3%
Trailing 12 Months
108.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 6.8M | 9.4M | 0 | 14.7M |
2022 | 1.2M | 1.5M | 2.3M | 4.3M |
2021 | 2.0M | 0 | 1.5M | 1.3M |
2020 | 5.0M | 4.8M | 4.0M | 2.9M |
2019 | 3.7M | 4.1M | 4.5M | 4.9M |
2018 | 1.0M | 1.5M | 2.4M | 3.2M |
2017 | 780.0K | 709.0K | 711.0K | 784.5K |
2016 | 1.2M | 1.1M | 990.0K | 885.0K |
2015 | 0 | 0 | 1.2M | 1.2M |
2014 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jan 30, 2024 | dale stephen | sold | -103,980 | 21.5502 | -4,825 | chief medical officer |
Jan 29, 2024 | dale stephen | sold | -127,416 | 17.8005 | -7,158 | chief medical officer |
Jan 29, 2024 | bair teresa brophy | sold | -36,544 | 17.8005 | -2,053 | chief legal officer |
Jan 29, 2024 | doyle thomas james | sold | -41,261 | 17.8005 | -2,318 | svp, finance & accounting |
Jan 29, 2024 | ford kathleen | sold | -26,629 | 17.8005 | -1,496 | chief operating officer |
Jan 24, 2024 | wilson troy edward | sold | -1,841,980 | 20.23 | -91,052 | president and ceo |
Jan 24, 2024 | wilson troy edward | acquired | 550,594 | 6.04703 | 91,052 | president and ceo |
Jan 02, 2024 | doyle thomas james | acquired | - | - | 21,250 | svp, finance & accounting |
Jan 02, 2024 | bair teresa brophy | acquired | - | - | 46,250 | chief legal officer |
Jan 02, 2024 | powl brian t. | acquired | - | - | 15,000 | chief commercial officer |
Which funds bought or sold KURA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | new | - | 86.00 | 86.00 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 2.89 | 22,271,000 | 58,062,000 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 130 | 11,085,300 | 15,287,700 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.4 | 183,194 | 504,364 | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | reduced | -50.65 | -70,000 | 248,000 | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | sold off | -100 | -101,000 | - | -% |
Feb 15, 2024 | Legal & General Group Plc | unchanged | - | 281,857 | 770,553 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | new | - | 1,413,770 | 1,413,770 | -% |
Feb 15, 2024 | Virtus ETF Advisers LLC | reduced | -10.17 | 32,751 | 111,402 | 0.07% |
Feb 15, 2024 | ALETHEA CAPITAL MANAGEMENT, LLC | unchanged | - | 1,843,340 | 5,039,400 | 5.81% |
Unveiling Kura Oncology Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Kura Oncology Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Kura Oncology Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -100.0% | - | 3,216 | 2,861 | 2,271 | 1,090 | 564 | 329 | 295 | 311 | 310 | 356 | 559 | 818 | 1,119 | 1,471 | 1,396 | 1,022 | 1,030 | 1,048 | 1,047 | 624 |
Operating Expenses | 16.9% | 46,762 | 40,003 | 36,566 | 35,156 | 36,594 | 35,333 | 32,782 | 33,038 | 33,677 | 30,896 | 26,332 | 24,194 | 21,173 | 20,200 | 18,963 | 17,674 | 15,891 | 14,951 | 16,634 | 15,982 | 15,276 |
S&GA Expenses | 20.4% | 14,229 | 11,821 | 11,374 | 12,488 | 11,621 | 11,075 | 11,869 | 12,082 | 11,310 | 10,572 | 8,808 | 7,593 | 7,476 | 7,625 | 5,499 | 5,134 | 4,451 | 4,569 | - | - | - |
R&D Expenses | 15.4% | 32,533 | 28,182 | 25,192 | 22,668 | 24,973 | 24,258 | 20,913 | 20,956 | 22,367 | 20,324 | 17,524 | 16,601 | 13,697 | 12,575 | 13,464 | 12,540 | 11,440 | 10,382 | - | - | - |
Interest Expenses | 1.8% | 394 | 387 | 364 | - | - | - | - | - | - | 108 | 144 | 146 | 144 | 144 | 142 | 145 | 148 | 145 | 193 | 252 | 267 |
Net Income | -15.1% | -42,786 | -37,174 | -34,069 | -33,114 | -35,504 | -34,769 | -32,453 | -32,743 | -33,366 | -30,694 | -26,159 | -23,769 | -20,487 | -19,210 | -17,865 | -16,392 | -14,943 | -13,940 | -16,097 | -15,007 | -14,739 |
Net Income Margin | 30.0% | -10.37* | -14.82* | -20.26* | -31.93* | -59.47* | -88.95* | -97.76* | -108.18* | -83.42* | -49.49* | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -33.5% | -34,324 | -25,713 | -35,908 | -26,542 | -21,391 | -30,525 | -32,230 | -23,468 | -25,317 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -5.2% | 449 | 474 | 495 | 426 | 456 | 448 | 471 | 499 | 534 | 561 | 585 | 620 | 647 | 340 | 353 | 226 | 242 | 255 | 266 | 170 | 182 |
Current Assets | -6.0% | 432 | 460 | 486 | 416 | 446 | 436 | 460 | 487 | 522 | 549 | 574 | 611 | 637 | 329 | 342 | 221 | 240 | 253 | 264 | 168 | 181 |
Cash Equivalents | 29.8% | 37.00 | 29.00 | 49.00 | 27.00 | 52.00 | 91.00 | 39.00 | 34.00 | 91.00 | 39.00 | 39.00 | 111 | 325 | 77.00 | 135 | 34.00 | 26.00 | 55.00 | 122 | 18.00 | 16.00 |
Net PPE | -9.6% | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 0.00 | - | - | - | - |
Liabilities | 17.9% | 52.00 | 44.00 | 35.00 | 31.00 | 36.00 | 28.00 | 22.00 | 22.00 | 27.00 | 27.00 | 26.00 | 34.00 | 36.00 | 33.00 | 31.00 | 23.00 | 23.00 | 21.00 | 19.00 | 20.00 | 21.00 |
Current Liabilities | 28.1% | 35.00 | 28.00 | 24.00 | 19.00 | 24.00 | 25.00 | 18.00 | 18.00 | 22.00 | 22.00 | 21.00 | 25.00 | 26.00 | 22.00 | 19.00 | 15.00 | 16.00 | 13.00 | 11.00 | 12.00 | 14.00 |
Long Term Debt | 0.5% | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | - | - | - | - | - | - | 4.00 | 4.00 | 5.00 | 6.00 | 7.00 | 7.00 | 8.00 | 8.00 | 8.00 | 8.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | 3.00 | 3.00 | 3.00 | 2.00 | 1.00 | 0.00 | - | - | - | - |
LT Debt, Non Current | 0.5% | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | - | - | - | - | - | - | 4.00 | 4.00 | 5.00 | 6.00 | 7.00 | 7.00 | 8.00 | 8.00 | 8.00 | 8.00 |
Shareholder's Equity | -7.6% | 397 | 430 | 460 | 395 | 420 | 420 | 449 | 476 | 507 | 534 | 559 | 586 | 611 | 306 | 322 | 203 | 219 | 234 | 247 | 150 | 161 |
Retained Earnings | -6.3% | -721 | -678 | -640 | -602 | -568 | -535 | -500 | -465 | -432 | -400 | -366 | -333 | -302 | -276 | -252 | -232 | -212 | -195 | -178 | -163 | -149 |
Additional Paid-In Capital | 0.7% | 1,120 | 1,112 | 1,105 | 1,004 | 997 | 965 | 957 | 948 | 941 | 934 | 926 | 919 | 913 | 583 | 574 | 435 | 431 | 428 | 425 | 313 | 311 |
Shares Outstanding | 0.1% | 74.00 | 74.00 | 74.00 | 68.00 | 68.00 | 67.00 | 67.00 | 67.00 | 66.00 | 66.00 | 66.00 | 66.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 777 | - | - | - | 1,200 | - | - | - | 1,300 | - | - | - | 878 | - | - | - | 822 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -18.2% | -34,308 | -29,027 | -25,617 | -35,872 | -26,530 | -21,010 | -30,341 | -32,181 | -23,366 | -24,594 | -28,074 | -28,517 | -18,308 | -16,966 | -14,734 | -19,822 | -13,933 | -12,145 | -14,431 | -14,251 | -10,211 |
Share Based Compensation | 1.1% | 7,167 | 7,090 | 6,987 | 6,838 | 6,805 | 6,355 | 6,508 | 6,650 | 6,397 | 6,114 | 5,993 | 5,075 | 3,742 | 3,360 | 2,552 | 3,153 | 2,439 | 2,452 | 2,249 | 2,269 | 1,716 |
Cashflow From Investing | 393.0% | 42,195 | 8,559 | -46,326 | 11,129 | -47,318 | 71,810 | 33,097 | -24,962 | 74,061 | 22,545 | -37,221 | -186,220 | -60,190 | -45,520 | -21,687 | 27,461 | -15,257 | -55,752 | 8,876 | 15,808 | 4,618 |
Cashflow From Financing | 722.6% | 691 | 84.00 | - | - | 34,713 | 880 | 2,669 | 303 | 794 | 2,258 | -6,566 | 79.00 | 327,036 | 4,683 | 137,368 | 247 | 583 | 559 | 109,857 | 102 | 1,144 |
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Operating Expenses: | |||
Research and development | $ 115,235 | $ 92,812 | $ 84,721 |
General and administrative | 50,569 | 47,053 | 46,537 |
Total operating expenses | 165,804 | 139,865 | 131,258 |
Other Income (Expense): | |||
Interest and other income, net | 14,722 | 4,254 | 1,206 |
Interest expense | (1,549) | (229) | (414) |
Total other income, net | 13,173 | 4,025 | 792 |
Net Loss | $ (152,631) | $ (135,840) | $ (130,466) |
Net loss per share, diluted | $ (2.08) | $ (2.03) | $ (1.97) |
Net loss per share, basic | $ (2.08) | $ (2.03) | $ (1.97) |
Weighted average number of shares used in computing net loss per share, basic | 73,229 | 66,990 | 66,352 |
Weighted average number of shares used in computing net loss per share, diluted | 73,229 | 66,990 | 66,352 |
Comprehensive Loss: | |||
Net loss | $ (152,631) | $ (135,840) | $ (130,466) |
Other comprehensive income (loss): | |||
Unrealized gain (loss) on marketable securities and foreign currency | 6,761 | (6,243) | (1,835) |
Comprehensive loss | $ (145,870) | $ (142,083) | $ (132,301) |
BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 37,318 | $ 51,802 |
Short-term investments | 386,639 | 386,183 |
Prepaid expenses and other current assets | 8,524 | 8,441 |
Total current assets | 432,481 | 446,426 |
Property and equipment, net | 1,859 | 2,540 |
Operating lease right-of-use assets | 6,993 | 3,842 |
Other long-term assets | 7,602 | 3,498 |
Total assets | 448,935 | 456,306 |
Current liabilities: | ||
Accounts payable and accrued expenses | 33,757 | 21,739 |
Current operating lease liabilities | 1,506 | 2,318 |
Total current liabilities | 35,263 | 24,057 |
Long-term debt, net | 9,332 | 9,158 |
Long-term operating lease liabilities | 6,362 | 2,548 |
Other long-term liabilities | 705 | 265 |
Total liabilities | 51,662 | 36,028 |
Commitments and contingencies (Note 8) | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding | ||
Common stock, $0.0001 par value; 200,000 shares authorized; 74,350 and 68,314 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 7 | 7 |
Additional paid-in capital | 1,119,976 | 997,111 |
Accumulated other comprehensive loss | (1,271) | (8,032) |
Accumulated deficit | (721,439) | (568,808) |
Total stockholders' equity | 397,273 | 420,278 |
Total liabilities and stockholders' equity | $ 448,935 | $ 456,306 |